[The susceptibility of Aspergillus and Penicillium to recent antimycotics]

A B Macura1, B Pawlik, I Szczepko

  • 1Zakład Mykologii Instytutu Mikrobiologii Collegium Medicum U J w Krakowie.

Insights

Terbinafine demonstrated the highest effectiveness against Aspergillus and Penicillium clinical isolates, inhibiting 88.9% at 1 mg/l in Czapek Dox medium. Antifungal drug efficacy varied significantly based on the specific mold and testing medium used.

Area of Science:

  • Medical Mycology
  • Antimicrobial Susceptibility Testing

Background:

  • Clinical isolates of Aspergillus and Penicillium species are significant causes of fungal infections.
  • Evaluating the in vitro antifungal activity of various drugs is crucial for guiding treatment decisions.

Purpose of the Study:

  • To assess the in vitro antifungal activity of four drugs (amorolfine, cyclopirox, itraconazole, terbinafine) against clinical isolates of Aspergillus and Penicillium.
  • To compare the efficacy of these drugs using two different culture media: Yeast Nitrogen Base (YNB) and Czapek Dox (CD).

Main Methods:

  • A total of 54 mold strains (32 Aspergillus, 22 Penicillium) from clinical samples were tested.
  • The broth dilution method was employed to determine Minimum Inhibitory Concentrations (MICs) at drug concentrations of 0.1, 1, 10, and 100 mg/l.
  • Two distinct media, Yeast Nitrogen Base (YNB) and Czapek Dox (CD), were utilized for susceptibility testing.

Main Results:

  • Terbinafine was the most effective drug, inhibiting 88.9% of strains at 1 mg/l in CD medium. In YNB, 50% of strains were inhibited at 1 mg/l or less.
  • Itraconazole showed good in vitro activity, inhibiting 77.8% of strains at 10 mg/l or less in CD medium, with Aspergillus fumigatus and Aspergillus flavus being most susceptible.
  • Cyclopirox and amorolfine exhibited lower efficacy, with most strains requiring concentrations of 100 mg/l or higher for inhibition, and results varied between YNB and CD media.

Conclusions:

  • Terbinafine is a highly effective antifungal agent against clinical isolates of Aspergillus and Penicillium in vitro.
  • The choice of testing medium significantly influences the observed antifungal susceptibility results.
  • Antifungal drug efficacy varies among different mold species, necessitating species-specific susceptibility testing.

Related Concept Videos

Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...